Observational Study of Viral BIOmarkers and microRNAs in Tumors Orofarynx and Occult Tumors Positive for Papilloma Virus

RecruitingOBSERVATIONAL
Enrollment

142

Participants

Timeline

Start Date

April 4, 2022

Primary Completion Date

April 4, 2024

Study Completion Date

April 4, 2029

Conditions
Squamous Cell Carcinoma of the OropharynxCarcinomas of Unknown Primary SiteHigh-risk Human Papillomavirus InfectionLiquid BiopsyLymph Node MetastasisOccult Tumor of the Head and Neck Area
Interventions
DIAGNOSTIC_TEST

Study of Viral BIOmarkers and microRNAs in Tumors Orofarynx

The prospective observational study involves the collection of tissue, blood and saliva samples from OPSCC and occult T patients for detection of HPV-DNA/RNA, miRNA and mutation profile from DNA with centralized analysis of samples at IRCCS Regina Elena National Cancer Institute.

Trial Locations (1)

00144

RECRUITING

"Regina Elena National Cancer Institute", Rome

All Listed Sponsors
collaborator

Istituto Clinico Humanitas

OTHER

collaborator

Istituto Europeo di Oncologia

OTHER

collaborator

Azienda Policlinico Umberto I

OTHER

collaborator

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER

collaborator

University of Firenze and Siena, Napoli, Italy

OTHER

collaborator

Weizmann Institute of Science

OTHER

lead

Regina Elena Cancer Institute

OTHER